Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Vmn2r94 Inhibitors

Vmn2r94 inhibitors are a class of chemical compounds that interact with the Vmn2r94 receptor, which is a member of the vomeronasal type-2 receptor family (V2Rs). The vomeronasal organ (VNO), where these receptors are predominantly expressed, is an olfactory structure involved in the detection of pheromones, chemical signals that elicit specific behavioral or physiological responses among members of the same species. Vmn2r94 receptors are G protein-coupled receptors (GPCRs), which means they transduce signals into cells via the interaction with G proteins. The GPCRs are characterized by their seven transmembrane domains and are known to play crucial roles in cellular signal transduction by responding to various ligands, including hormones, neurotransmitters, and environmental stimuli.

Inhibitors of Vmn2r94 are compounds designed to selectively bind to these receptors and block their normal function. This inhibition alters the signal that would normally be propagated upon ligand binding. The specificity of Vmn2r94 inhibitors is particularly significant because V2Rs, including Vmn2r94, are encoded by a diverse gene family with a large number of variants in different species, which can lead to species-specific responses to certain chemical signals. The molecular interactions involved in the inhibition process are complex and depend on the chemical structure of both the inhibitor and the receptor. The binding of an inhibitor to Vmn2r94 can involve multiple types of interactions, such as hydrogen bonding, hydrophobic interactions, and van der Waals forces. These interactions can induce conformational changes in the receptor structure, thus preventing the typical action of the receptor's natural ligand. The study of Vmn2r94 inhibitors involves exploring these intricate molecular dynamics to understand how these compounds exert their effects at the cellular level.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Quinidine

56-54-2sc-212614
10 g
$104.00
3
(1)

Quinidine is a voltage-gated sodium channel blocker that can indirectly inhibit Vmn2r94 by affecting the electrical signaling which may be necessary for the proper functioning of the olfactory system, where Vmn2r94 is predominantly expressed.

Capsazepine

138977-28-3sc-201098
sc-201098A
5 mg
25 mg
$148.00
$459.00
11
(1)

Capsazepine is a TRPV1 antagonist that can potentially reduce the activity of Vmn2r94 by modulating the thermal and pain sensory pathways, which might interact with the vomeronasal system where Vmn2r94 is active.

Ruthenium red

11103-72-3sc-202328
sc-202328A
500 mg
1 g
$188.00
$250.00
13
(1)

Ruthenium Red is a polycationic dye that inhibits various ion channels, including calcium channels. Since calcium signaling is crucial in olfactory transduction, its inhibition could lead to reduced activity of Vmn2r94 by impairing the signal transduction process.

Diltiazem

42399-41-7sc-204726
sc-204726A
1 g
5 g
$209.00
$464.00
4
(1)

Diltiazem is an L-type calcium channel blocker. By inhibiting these channels, it could decrease the excitability of neurons in the vomeronasal organ, thereby potentially decreasing the functional activity of Vmn2r94.

(+)-Bicuculline

485-49-4sc-202498
sc-202498A
50 mg
250 mg
$82.00
$281.00
(1)

Bicuculline is a GABA_A receptor antagonist. Since GABAergic signaling can modulate sensory processing, including olfaction, blocking this pathway may reduce the functional activity of Vmn2r94.

6-Cyano-7-nitroquinoxaline-2,3-dione

115066-14-3sc-505104
10 mg
$208.00
2
(0)

CNQX is an AMPA/kainate receptor antagonist which could decrease excitatory neurotransmission in the vomeronasal organ, potentially leading to decreased activation of Vmn2r94.

Riluzole

1744-22-5sc-201081
sc-201081A
sc-201081B
sc-201081C
20 mg
100 mg
1 g
25 g
$20.00
$193.00
$213.00
$317.00
1
(1)

Riluzole is a glutamate release inhibitor and by decreasing glutamatergic signaling, it may indirectly inhibit the activity of Vmn2r94, as glutamate is a principal neurotransmitter in olfactory signaling.

Concanamycin A

80890-47-7sc-202111
sc-202111A
sc-202111B
sc-202111C
50 µg
200 µg
1 mg
5 mg
$66.00
$167.00
$673.00
$2601.00
109
(2)

Concanamycin A is a V-ATPase inhibitor that could indirectly inhibit Vmn2r94 by disrupting the proton gradient necessary for neurotransmitter loading into vesicles, thus affecting neuronal communication in the vomeronasal organ where Vmn2r94 is located.